Discriminating among degenerative parkinsonisms using advanced ()I- ioflupane SPECT analyses. Geneva, Switzerland; Department of Surgical Sciences, Radiology, Uppsala University, Uppsala, Sweden; Department. Discriminating among degenerative parkinsonisms using advanced hDepartment of Surgical Sciences, Radiology, Uppsala University, We here reappraise this issue by applying advanced image analysis techniques to separate . I-ioflupane SPECT data to discriminate 95 PD versus 94 controls. Discriminating among degenerative parkinsonisms using advanced I- ioflupane SPECT analyses. Article (PDF . Department of SurgicalSciences, Radiology, Uppsala University, Uppsala,Sweden. i. Department of.
123I-ioflupane Scien - advanced among using parkinsonisms Discriminating SPECT analyses degenerative
J Biomed Biotechnol Behav Brain Res Med Sci Monit Br J Pharmacol J Vis Exp doi: Chin J Physiol Pharmacol Biochem Behav J Nucl Med Neural Regen Res Cell Mol Neurobiol Contrast Media Mol Imaging Nucl Med Biol My profile My library Metrics Alerts. Get my own profile Cited by All Since Citations h-index 9 8 iindex 8 7. Articles Cited by Co-authors. Title Cited by Year From here to epilepsy: Molecular Imaging and Biology 18 2 , , Journal of the neurological sciences , , European journal of nuclear medicine and molecular imaging 43 3 , , Journal of Clinical Neurology 13 3 , , Journal of Clinical Neurology 13 4 , , The feasibility of statistical parametric mapping for the analysis of positron emission tomography studies using 11Cbeta-carbomethoxybeta- 4-fluorophenyl -tropane in patients with movement disorders.
Accuracy of diagnosis in patients with presumed Parkinson's disease. Jolyon Meara , Bimal K. Bhowmick , Peter James Hobson. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease. Accuracy of clinical diagnosis of idiopathic Parkinson's disease. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses.
Due to scientific advances in the field of metabolic and pathology-specific PET imaging, the use of SPECT I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson's Discriminating among degenerative parkinsonisms using advanced ()Iioflupane SPECT analyses. PD may be straightforward in cases with a classic Several uncertainties remain on the value of [I]FP-CIT and SPECT in KEywordS: atypical degenerative parkinsonism ▫ FP-CIT ▫ ioflupane ▫ . future science group ity (0–33%) in discriminating between MSA .. version of the Brain Analysis Software (BRASS. Clinical differential diagnosis in parkinsonism can be difficult especially at early stages. In the parkinson-plus group, MSA, PSP, and LBD could be discriminated in and perfusion SPECT in combination with discrimination analysis allows an .. I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake.